Biologic Excipients Market Projected to Reach USD 2,241.8 Million by 2034 at a 4.10% of CAGR

The global biologic excipient market is poised for steady growth over the next decade, with an estimated market value of USD 1,500 million in 2024. The market is projected to reach USD 2,241.8 million by 2034, advancing at a compound annual growth rate (CAGR) of 4.10% during the forecast period from 2024 to 2034.

Biologic excipients play a critical role in the formulation and stability of biologic drugs, which are increasingly used in the treatment of various chronic diseases such as cancer, autoimmune disorders, and cardiovascular diseases. As the global demand for biologic drugs rises, so too does the need for high-quality excipients that ensure their safety and efficacy.

The biologic excipient market is benefiting from technological advancements in drug formulation and increased investment in biopharmaceutical research and development. This upward trend is expected to continue as pharmaceutical companies focus on developing more sophisticated drug delivery systems that require innovative excipient solutions.

In conclusion, the global biologic excipient market is set for sustained growth, driven by rising demand for biologic drugs and the need for advanced formulation techniques. Industry stakeholders are encouraged to invest in innovation to meet the evolving needs of the biopharmaceutical sector.

Key Drivers:

• Increasing Demand for Biologic Drugs: The growing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is driving the demand for biologic drugs, which in turn is boosting the need for biologic excipients.
• Innovation in Drug Delivery Systems: Advances in drug delivery technologies are creating new opportunities for excipient manufacturers, especially as the industry shifts toward more complex biologics.
• Regulatory Support: Stringent regulations governing biologic drug production are compelling manufacturers to focus on excipients that enhance the safety and effectiveness of these therapies.

Key Takeaways:

• Market Size: The global biologic excipient market is projected to grow from US$ 1,500 million in 2024 to US$ 2,241.8 million by 2034.
• Growth Rate: The market is expected to register a steady CAGR of 4.10% from 2024 to 2034.
• Demand for Biologics: Rising demand for biologic drugs is a key factor driving market growth.
• Technological Advancements: Innovations in drug delivery systems and excipient formulations are creating new growth opportunities.
• Focus on Safety and Efficacy: Regulatory frameworks are encouraging the development of excipients that ensure the stability and safety of biologic drugs.

Competitive Landscape

Companies in the biologic excipients industry are actively looking to bolster their positions through collaborations and acquisitions with established and up-and-coming competitors. Excipients are being produced in large quantities at local facilities by the manufacturers, who then sell them to biological drug producers at extremely low costs.

Leading companies in the field are concentrating on developing biologic excipients. Adopting IPEC principles is anticipated to encourage adherence to protocols, improving medicine efficacy and product safety in manufacturing and distribution.

• FMC Corporation offers a diverse portfolio of excipients used in pharmaceutical formulations, including biologic drugs. Their excipients are known for their high quality, functionality, and regulatory compliance.
• Wacker Chemie AG is a leading provider of specialty chemicals, including excipients for the pharmaceutical industry. They offer a range of excipients suitable for biologic drug formulations, including binders, fillers, and coatings.

Key Companies Profiled:

• FMC Corporation
• Wacker Chemie AG
• Evonik Industries AG
• Ashland Global Holdings Inc.
• Archer-Daniels-Midland Co.
• Roquette Freres S.A.
• The Dow Chemical Company
• Colorcon Inc.
• Signet Chemical Co. Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd

Biologic Excipient Market Segmentation by Category:

By Excipient Type:

• Polymers
• Sugar Alcohols
• Polysorbates
• Inorganic Salts
• Amino Acids
• Surfactants
• Others

By End User:

• Biopharmaceutical Manufacturers
• Contract Research Organizations
• Contract Manufacturing Organizations
• Research Organizations

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• South Asia and Pacific
• East Asia
• The Middle East and Africa

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube